z-logo
open-access-imgOpen Access
Pemodelan Enterprise Arsitektur Sistem Informasi Penjualan Obat Menggunakan Kerangka TOGAF ADM
Author(s) -
Umi Faddillah,
Nurfia Oktaviani Syamsiah,
Indah Purwandani
Publication year - 2019
Publication title -
indonesian journal on software engineering (ijse)/ijse (indonesian journal on software engineering)
Language(s) - English
Resource type - Journals
eISSN - 2714-9935
pISSN - 2461-0690
DOI - 10.31294/ijse.v5i1.5871
Subject(s) - the open group architecture framework , enterprise architecture , business architecture , blueprint , architecture framework , business process , architecture , computer science , enterprise architecture framework , process management , business , engineering management , software engineering , knowledge management , systems architecture , engineering , work in process , marketing , mechanical engineering , art , visual arts
Enterprise information system architecture has covered various fields, one of which is the pharmaceutical industry which has also changed significantly. Pharmaceutical companies and all business lines around the world are forced to reconsider their business priorities and strategies to deal with uncertainty, volatility and complexity. Where it will be handled in the presence of an integrated system. In this research the implementation of information system technology is carried out by implementing the TOGAF ADM framework that will help companies in architectural modeling starting from designing system architecture, business process architecture, drug sales information system architecture, technology architecture, several proposed architectural designs for business opportunities, and proposals system changes running. The result is that the enterprise modeling information system sales architecture to produce architectural blueprints can be done in six stages in the TOGAF ADM framework. Keywords: TOGAF, Sales, Pharmaceutical

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here